Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's Locations section has been expanded to include new sites across the United States and international locations such as Australia and European regions. This broadens the list of enrolling centers and may affect where patients can participate.
    Difference
    2%
    Check dated 2025-12-23T21:32:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Publications note updated to state that PubMed entries are automatically filled from PubMed and may or may not pertain to the study, replacing the previous wording. The revision/version tag was updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T13:47:43.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page; this site-wide operational notice described potential delays and updated operating status for the NIH Clinical Center. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:24:55.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page content and structure appear unchanged; no additions or deletions were detected.
    Difference
    0.2%
    Check dated 2025-11-03T21:31:02.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    2%
    Check dated 2025-10-06T06:38:20.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.3%
    Check dated 2025-09-29T03:15:48.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.